Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
3,970.00    10.00 (0.25%)
Bid:
3,974.00
Ask:
3,976.00
Spread: 2.00 (0.05%)
Market Cap: £14.99b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Acquisition

23 Jan 2013 09:00

RNS Number : 1738W
Halma PLC
23 January 2013
 



Halma plc ('Halma')

 

ACQUISITION OF BAODING LONGER PUMP

 

 

Halma, the leading safety, health and environmental technology group announces the completion on 23 January 2013 of the acquisition of Thinketron Precision Equipment Company Limited ('TPE') based in Hong Kong and its subsidiaries Baoding Longer Precision Pump Co., Ltd ('Longer Pump') based in China and Langer Instruments Corporation ('LIC') based in the USA.

 

Longer Pump manufactures and markets peristaltic, syringe and gear pumps used in laboratory, medical and industrial applications. LIC is Longer Pump's distributor in the USA.

 

The initial cash consideration was RMB 237 million (£23.7 million) for the share capital of TPE. Deferred consideration of RMB 3 million (£0.3 million), which is adjustable RMB for RMB if the net tangible asset value (NTAV) is over/under a targeted amount, is payable upon agreement of the NTAV. The targeted NTAV includes approximately RMB 22.5 million (£2.25 million) of cash.

 

Unaudited accounts for the year ended 31 December 2012 show adjusted operating profit of RMB 23.5 million (£2.35 million). Audited accounts for the year ended 31 December 2011 show adjusted operating profit of RMB 18.2 million (£1.82 million).

 

Existing management of Longer Pump and LIC will remain in place and will continue to operate the business supported by new Board members appointed from within Halma China. The acquisition, which is expected to be immediately earnings enhancing, has been funded from Halma's cash and debt facilities.

 

Longer Pump will join Halma's Health & Analysis sector within the Fluid Technology sub-sector adding complementary high-value fluid handling products which are sold through a large sales network in China. Approximately 80% of Longer Pump's revenue is generated from China.

 

 

Andrew Williams, Halma's Chief Executive, commented:

 

"Longer Pump's alignment with Halma's growth drivers is strong. Sales of their products are driven by increasing demand for healthcare and healthcare research, as well as the urbanisation and industrialisation within China. Their significant local market knowledge and technical resources will help our Fluid Technology sub-sector accelerate growth in this important region.

 

There are also opportunities for Halma to contribute to the growth of Longer Pump, utilising both the network of regional hub offices which Halma has established within China and the worldwide reach of our Fluid Technology businesses."

 

 

 

 

For further information please contact:

 

Halma plc

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

 

 

+44 (0)1494 721111

MHP Communications

Rachel Hirst/Andrew Jaques

+44 (0)20 3128 8100

 

Notes

 

1.

Exchange rate used: RMB 10/£1.

 

2.

Longer Pump has been specialising in the manufacture of peristaltic pumps, syringe pumps, gear pumps and pump accessories for 15 years. It has significant IP and R&D capabilities with sales to a diverse, mainly non-OEM, customer base.

 

Peristaltic pumps provide reliable solutions for demanding fluid handling applications in the laboratory, industrial and OEM markets.

 

Growth prospects in their core geographic market of China for peristaltic pumps are strong. One industry forecast expects market growth of approximately 12% for the next several years, before increasing to over 20% in 2016.

 

3.

Halma buys successful businesses in safety, health and environmental markets and helps them grow further through investment targeted towards increasing innovation, management development and international expansion. In the past 10 years Halma has spent approximately £400m acquiring 30 businesses with deal sizes ranging from £70m down to below £1m. Although businesses have been acquired in all areas of our activity, the majority of recent acquisitions has been in the Health & Analysis Sector.

 

4.

This statement is not intended to constitute a profit forecast for the current financial period or for any future period. In addition, this statement should not be taken to mean that the earnings per share of Halma will necessarily match or exceed the historic reported earnings per share of Halma.

 

5.

A copy of this announcement, together with other information about Halma and its Fluid Technology businesses, may be viewed on our website: www.halma.com.

 

6.

Halma's next Interim Management Statement will be issued on 14 February 2013.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBJMPTMBATMJJ
Date   Source Headline
1st Jun 20103:31 pmRNSLaunch of ADR Programme
1st Jun 201011:45 amRNSTotal Voting Rights
4th May 201011:00 amRNSTotal Voting Rights
4th May 201010:54 amRNSHolding(s) in Company
29th Apr 20109:30 amRNSTreasury Stock
14th Apr 201010:23 amRNSHolding(s) in Company
12th Apr 201010:40 amRNSHolding(s) in Company
8th Apr 20104:01 pmRNSTreasury Stock
1st Apr 20109:51 amRNSTotal Voting Rights
24th Mar 201011:40 amRNSHolding(s) in Company
3rd Mar 20102:26 pmRNSDirector/PDMR Shareholding
1st Mar 20104:06 pmRNSTotal Voting Rights
11th Feb 20107:00 amRNSInterim Management Statement
1st Feb 20104:26 pmRNSTotal Voting Rights
22nd Jan 20107:00 amRNSAcquisition
19th Jan 201011:45 amRNSAdditional Listing
13th Jan 201011:35 amRNSBlocklisting Interim Review
4th Jan 20105:41 pmRNSTotal Voting Rights
4th Jan 20105:35 pmRNSTreasury Stock
23rd Dec 200911:08 amRNSDirector/PDMR Shareholding
9th Dec 20092:32 pmRNSTreasury Stock
9th Dec 20092:19 pmRNSDirector/PDMR Shareholding
9th Dec 200911:58 amRNSAdditional Listing
3rd Dec 20091:05 pmRNSDoc re. Half Year Report 2009/10
3rd Dec 20097:00 amRNSHalf Yearly Report
1st Dec 200910:44 amRNSTotal Voting Rights
26th Nov 200910:29 amRNSNotice of Results
23rd Nov 20094:06 pmRNSHolding(s) in Company
3rd Nov 200912:56 pmRNSTotal Voting Rights
16th Oct 200911:19 amRNSHolding(s) in Company
2nd Oct 20099:47 amRNSTotal Voting Rights
24th Sep 20095:21 pmRNSDirector/PDMR Shareholding
1st Sep 20092:05 pmRNSTotal Voting Rights
20th Aug 20093:48 pmRNSBlocklisting Interim Review
18th Aug 20094:10 pmRNSAnnual Information Update
7th Aug 200911:44 amRNSDirector/PDMR Shareholding
3rd Aug 20093:56 pmRNSTotal Voting Rights
31st Jul 200911:12 amRNSResult of AGM
30th Jul 20097:00 amRNSAGM Statement
14th Jul 20093:04 pmRNSDirector/PDMR Shareholding
8th Jul 200912:15 pmRNSTreasury Stock
8th Jul 200912:12 pmRNSDirector/PDMR Shareholding
2nd Jul 20099:52 amRNSHolding(s) in Company
1st Jul 20095:08 pmRNSTotal Voting Rights
29th Jun 200910:52 amRNSAnnual Financial Report
22nd Jun 20094:25 pmRNSHolding(s) in Company
17th Jun 200910:34 amRNSAdditional Listing
16th Jun 20097:00 amRNSFinal Results
10th Jun 200911:49 amRNSNotice of Results
1st Jun 200911:05 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.